ADVOCATE. CONNECT. INNOVATE.

Multi-State Life Sciences Association Congressional Briefing: America’s Preparedness to Infectious Diseases and Biothreats

Washington, DC - Rayburn 2322

5/14/2018

12:00pm - 1:15pm

Contact: Danielle Mitchell
Contact Email: dmitchell@califesciences.org

America’s Preparedness to Infectious Diseases and Biothreats

Hosted in cooperation with
Hon. Susan Brooks (R-IN) and Hon. Anna G. Eshoo (D-CA); Co-Chairs, Congressional Biodefense Caucus

May 14, 2018 | 12:00 -1:15 PM

In 2006, Congress passed the Pandemic and All-Hazards Preparedness Act (PAHPA), which established the Biomedical Advanced Research and Development Authority (BARDA) to protect the public against chemical, biological, radiological, nuclear defense, and pandemic influenza threats. Since its inception, BARDA has supported advanced research and development of more than 190 potential medical countermeasures for various threats.

Recent outbreaks, such as Ebola and Zika, have revived a nationwide debate over U.S. preparedness for emerging infectious diseases and emphasized the need for robust public-private partnerships to develop medical countermeasures. As Congress considers the reauthorization of PAHPA this year, come learn about our nation’s biodefense and emergency preparedness efforts and how government and industry work together to develop the vaccines, drugs, and diagnostics needed to protect public health.

Moderator:

Jennifer Nieto Carey, Vice President, Federal Government Relations & Alliance Development, California Life Sciences Association

Panelists:

Rick Bright, Deputy Assistant Secretary for Preparedness and Response and Director of the Biomedical Advanced Research and Development Authority (BARDA), Department of Health and Human Services (HHS)

Rajeev Venkayya, President, Global Vaccine Business Unit, Takeda Pharmaceuticals

Clem Lewin, Associate Vice President, Research & Development Strategy, Sanofi

Chris Frech, Senior VP, Government Affairs, Emergent Biosolutions and Co-Chair of the Alliance for Biosecurity

Lunch will be served. Speakers will be available for individual Q&A after the program.

This event will be held in strict accordance with House and Senate Ethics rules. Food and refreshments of a nominal value will be provided as allowed by House Rule 25, clause 5(a)(4)(A) and Senate Rule 35.1(d)(1).

Please RSVP directly to Danielle Mitchell at dmitchell@califesciences.org.